Literature DB >> 33845191

Home Self-tonometry Trials Compared with Clinic Tonometry in Patients with Glaucoma.

Elyse J McGlumphy1, Aleksandra Mihailovic1, Pradeep Y Ramulu1, Thomas V Johnson2.   

Abstract

PURPOSE: This study examined characteristics of intraocular pressure (IOP) as measured during home tonometry in comparison with in-clinic tonometry in patients with glaucoma.
DESIGN: Retrospective cross-sectional study of glaucoma patients who completed 1 week of self-tonometry at a single academic center. PARTICIPANTS: Patients with glaucoma who completed home tonometry trials with the iCare HOME tonometer (iCare USA) for any reason.
METHODS: Home IOP measurements were compared with in-clinic tonometry performed during the 5 visits preceding home tonometry. Maximum daily IOP was correlated to time of day. Generalized estimating equations were used to evaluate patient characteristics and clinic-derived variables that predicted differences between home and clinic IOP. MAIN OUTCOME MEASURES: IOP mean, maximum, minimum, range, standard deviation and coefficient of variation were compared between clinic and home tonometry. IOP mean daily maximum (MDM) and mean daily range were calculated to describe recurrent IOP spiking.
RESULTS: A total of 107 eyes from 61 patients were analyzed. Mean age was 63.2 years (standard deviation [SD], 14.0 years) and 59.0% were women. Mean clinic and home IOPs were 14.5 mmHg (SD, 4.7 mmHg) and 13.6 mmHg (SD, 5.1 mmHg). Home tonometry identified significantly higher maximum IOP, lower minimum IOP, and greater IOP range than clinic tonometry (P < 0.001). Maximum daily IOP occurred outside of clinic hours (8 am-5 pm) on 50% of days assessed and occurred between 4:30 am and 8 am on 24% of days. Mean daily maximum IOP exceeded maximum clinic IOP in 44% of patients and exceeded target IOP by 3 mmHg, 5 mmHg, or 10 mmHg in 31%, 15%, and 6% of patients, respectively. Patient characteristics that predicted significant deviations between MDM and mean clinic IOP or target IOP in multivariate models included younger age, male gender, and absence of prior filtering surgery.
CONCLUSIONS: Self-tonometry provides IOP data that supplements in-clinic tonometry and would not be detectable over daytime in-clinic diurnal curves. A subset of patients in whom home tonometry was ordered by their glaucoma clinician because of suspicion of occult IOP elevation demonstrated reproducible IOP elevation outside of the clinic setting. Such patients tended to be younger and male and not to have undergone previous filtering surgery.
Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glaucoma; Rebound tonometer; Remote monitoring; Risk factor; Tonometry

Mesh:

Year:  2021        PMID: 33845191      PMCID: PMC8501148          DOI: 10.1016/j.ogla.2021.03.017

Source DB:  PubMed          Journal:  Ophthalmol Glaucoma        ISSN: 2589-4196


  43 in total

1.  Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients.

Authors:  Sameh Mosaed; John H K Liu; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

2.  Intraocular pressure: a comparative analysis in two sexes.

Authors:  I A Qureshi
Journal:  Clin Physiol       Date:  1997-05

3.  Using Icare HOME tonometry for follow-up of patients with open-angle glaucoma before and after selective laser trabeculoplasty.

Authors:  Mona S Awadalla; Ayub Qassim; Mark Hassall; Thi T Nguyen; John Landers; Jamie E Craig
Journal:  Clin Exp Ophthalmol       Date:  2019-12-02       Impact factor: 4.207

4.  Home Tonometry Assists Glaucoma Drainage Device Management in Childhood Glaucoma.

Authors:  Michelle S Go; Navajyoti R Barman; Robert J House; Sharon F Freedman
Journal:  J Glaucoma       Date:  2019-09       Impact factor: 2.503

5.  Evaluation of a New Rebound Self-tonometer, Icare HOME: Comparison With Goldmann Applanation Tonometer.

Authors:  Daisuke Takagi; Akira Sawada; Tetsuya Yamamoto
Journal:  J Glaucoma       Date:  2017-07       Impact factor: 2.503

6.  Canadian Glaucoma Study: 2. risk factors for the progression of open-angle glaucoma.

Authors:  Balwantray C Chauhan; Frederick S Mikelberg; A Gordon Balaszi; Raymond P LeBlanc; Mark R Lesk; Graham E Trope
Journal:  Arch Ophthalmol       Date:  2008-08

7.  Evaluation of a self tonometer for home use.

Authors:  R C Zeimer; J T Wilensky; D K Gieser; M M Mori; J P Baker
Journal:  Arch Ophthalmol       Date:  1983-11

8.  Self-measurement with Icare HOME tonometer, patients' feasibility and acceptability.

Authors:  Barbara Cvenkel; Makedonka Atanasovska Velkovska; Vesna Dimovska Jordanova
Journal:  Eur J Ophthalmol       Date:  2019-01-11       Impact factor: 2.597

9.  Diurnal Intraocular Pressure Fluctuations with Self-tonometry in Glaucoma Patients and Suspects: A Clinical Trial.

Authors:  Jessie Huang; Paula Katalinic; Michael Kalloniatis; Michael P Hennessy; Barbara Zangerl
Journal:  Optom Vis Sci       Date:  2018-02       Impact factor: 1.973

10.  Associations with Intraocular Pressure in a Large Cohort: Results from the UK Biobank.

Authors:  Michelle P Y Chan; Carlota M Grossi; Anthony P Khawaja; Jennifer L Y Yip; Kay-Tee Khaw; Praveen J Patel; Peng T Khaw; James E Morgan; Stephen A Vernon; Paul J Foster
Journal:  Ophthalmology       Date:  2016-01-13       Impact factor: 12.079

View more
  2 in total

1.  A Google Trends Approach to Identify Distinct Diurnal and Day-of-Week Web-Based Search Patterns Related to Conjunctivitis and Other Common Eye Conditions: Infodemiology Study.

Authors:  Michael S Deiner; Gurbani Kaur; Stephen D McLeod; Julie M Schallhorn; James Chodosh; Daniel H Hwang; Thomas M Lietman; Travis C Porco
Journal:  J Med Internet Res       Date:  2022-07-05       Impact factor: 7.076

2.  The utility of home tonometry for peri-interventional decision-making in glaucoma surgery: Case series.

Authors:  Ariana M Levin; Elyse J McGlumphy; Craig J Chaya; Barbara M Wirostko; Thomas V Johnson
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.